Asaf Danziger, Chief Executive Officer at NovoCure Ltd (NVCR), sold 380,676 shares at $59.37 ($22.6M) on 2019-06-18, disclosed to the SEC on 2019-06-19.
Open-market sale of $22.6M NVCR by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $59.37 | 190,338 | $11.3M | 50.0% |
| 2 | $59.37 | 190,338 | $11.3M | 50.0% |
| Total | $59.37 avg | 380,676 | $22.6M | 100% |
| Filing → |
| NVCR | SELL | 2021-04-15 | $38.5M | — | Filing → |
| NVCR | SELL | 2020-12-22 | $61.4M | — | Filing → |
| NVCR | SELL | 2020-09-17 | $10.2M | — | Filing → |